POET Technologies Inc. ("POET" or the "Company") (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer, Photonic Integrated ...

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Chief Executive Officer Pascal Soriot buys 20,000 shares at GBP102.03, worth GBP2.0 million, on Thursday.

Graphene has lived up to its promise in the lab. Now, EU researchers are working on supporting its wider adoption in high-end ...